Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth

Abstract : no abstract
Document type :
Journal articles
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-01614947
Contributor : Lionel Spinelli <>
Submitted on : Wednesday, October 11, 2017 - 4:49:19 PM
Last modification on : Monday, April 29, 2019 - 4:01:48 PM

Links full text

Identifiers

Collections

Citation

Coralie Hoareau-Aveilla, Thibaud Valentin, Camille Daugrois, Cathy Quelen, Géraldine Mitou, et al.. Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. Journal of Clinical Investigation, American Society for Clinical Investigation, 2015, 125 (9), pp.3505--3518. ⟨10.1172/JCI78488⟩. ⟨hal-01614947⟩

Share

Metrics

Record views

89